{"id":380895,"date":"2020-11-13T09:18:27","date_gmt":"2020-11-13T14:18:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380895"},"modified":"2020-11-13T09:18:27","modified_gmt":"2020-11-13T14:18:27","slug":"ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/","title":{"rendered":"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOSTON, Nov.  13, 2020  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GG7oUXSl0G1fZXx9lUCLAwC4KO8GBiT9Ik9I3XT05cpWcGt817hnZa-00wnkxuWADYk6cUy6rBb2S5rO8GuoBg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Ziopharm Oncology<\/a>, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a fireside chat at the Jefferies Virtual London Healthcare Conference on November 19, 2020 at 1:45 pm ET.<\/p>\n<p align=\"justify\">To access the live webcast presentation, or the subsequent archived recording, please visit the \u201cInvestors\u201d section of the Ziopharm website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GWqHNfp50JN6MaymGhGY-wE4VjICNl7TTmWnx9dau62_PkPKq34uUbsDT5LL4CJ10MvLABUtXW7TUdgxuPIPEQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.ziopharm.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Ziopharm Oncology, Inc.<br \/><\/strong>Ziopharm is developing non-viral and cytokine-driven cell and gene therapies that weaponize the body\u2019s immune system to treat the millions of people globally diagnosed with a solid tumor each year. With its multiplatform approach, Ziopharm is at the forefront of immuno-oncology with a goal to treat any type of solid tumor. Ziopharm\u2019s pipeline is built for commercially scalable, cost effective T-cell receptor T-cell therapies based on its non-viral\u00a0<em>Sleeping Beauty<\/em>\u00a0gene transfer platform, a precisely controlled IL-12 gene therapy, and rapidly manufactured\u00a0<em>Sleeping Beauty<\/em>-enabled CD19-specific CAR-T program. The Company has clinical and strategic partnerships with the\u00a0National Cancer Institute,\u00a0The University of Texas MD Anderson Cancer Center\u00a0and others. For more information, please visit\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GWqHNfp50JN6MaymGhGY-9fYNJNLPDFKImSslcwchw8FP6a8a--IrriZDkkRzcfI4SUw2oGmH08_OgCmlMvB3Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.ziopharm.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pKG_kK1LqGpyZxPkikwLrIlBHo1iMfgUf29XVVTM0qXdsYXrWHBMvvPRBBim8YrL2XyyJZXQ4bPfUmJ-JrPXH8Ud2yvJmkVXVUDRSXqTf-Cw6g-nJjT-uR28ZFnIcOuQ-fbuSuN9gtTDFyaymzZqOKjiSlW6LJ4uWdeNT4If6cwLJBHmyFcpIRc6rZNHncfQzti0FHcIPQA1a0tJT08b9BUKKBnQbJQ0d3i7Ine2DWyGzy52sJY60JOpxayaCAZdZcFtU2yLN_jH07b3V0VG0BAqYl-kvDiuZx0gfVJChTnm35ann2zGHypP2EK6gU1ZGB8YpCFu8ztM_9zgwD_ARRBPiMG0fK_nigSfpZu33qwahFi5qQCVeHa7Pc6kqgd0aaQjx9Ug3YKWAYvR_PvYpTjQFo1eJTLOHLoEfdy28R8GW19QAxZxmSBzQoShH5rBIJyUzh8VFsmESduiCHDevBFV1qD7WlMMwsPpaOWjYXR5vaZJX8bjrmiBpykVpQjmBTgCNqmAlFh7OKtDoCmOlG6Ygii62-t7plQCdh55OfxhmtK6OyRT1NKQJyUOhg8HPu7GHesmmDkEY8e2uGyMnjzGu6XZv9ELrFf3SlgrYqIl26f85sjQEA1nd4plj7dhNZ-ycBJGdNEGsf53ngiIfQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/><\/a><\/u><br \/><strong>Investor Relations Contacts:<\/strong><br \/> Ziopharm Oncology:<br \/> Chris Taylor<br \/> VP, Investor Relations and Corporate Communications<br \/> T: 617.502.1881<br \/> E:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Spvb4DY2F1i08BePZRouKF95Xazd0v0ighqXh1l57UqcWlQHamtFZaAljFChzANdH7MUJ8oGFERTLFNGOt3HJCIzglt348WpnIumhbYmI28=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>ctaylor@ziopharm.com<\/u><\/a><\/p>\n<p>LifeSci Advisors:<br \/> Mike Moyer<br \/> Managing Director<br \/> T: 617.308.4306<br \/> E:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mGtrFnPZkR6pUdWSk2ZxjtQt7mVIYFhoBt0OIo-WUOdVd0rRL-LTLt244NwnxsLEXn1nXUEjIpRYoDt62_043VHEmVWHapZ022muKhVfSf41hoIiQZqfZZvP_bXxrMfS\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>mmoyer@lifesciadvisors.com<\/u><\/a><br \/><strong><br \/>Media Relations Contact:<\/strong><br \/> LifeSci Communications:<br \/> Patrick Bursey<br \/> T: 646.876.4932<br \/> E:\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bVsRfoN1wmHdHcID8X4DeDWBtHCt1oH8KJqEgAX5jPT-28Yv34WogIud4KsxIfVMUuaoIjg9lqlwno9uCaKO88PizaX-b6stKQ9Wep4FmUg=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">pbursey@lifescicomms.com<\/a><\/u><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/c722a196-78a6-4189-b3be-9d4508f2a11d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a fireside chat at the Jefferies Virtual London Healthcare Conference on November 19, 2020 at 1:45 pm ET. To access the live webcast presentation, or the subsequent archived recording, please visit the \u201cInvestors\u201d section of the Ziopharm website at www.ziopharm.com. About\u00a0Ziopharm Oncology, Inc.Ziopharm is developing non-viral and cytokine-driven cell and gene therapies that weaponize the body\u2019s immune system to treat the millions of people globally diagnosed with a solid tumor each year. With its multiplatform approach, Ziopharm is at the forefront of immuno-oncology with a goal to treat any type of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380895","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a fireside chat at the Jefferies Virtual London Healthcare Conference on November 19, 2020 at 1:45 pm ET. To access the live webcast presentation, or the subsequent archived recording, please visit the \u201cInvestors\u201d section of the Ziopharm website at www.ziopharm.com. About\u00a0Ziopharm Oncology, Inc.Ziopharm is developing non-viral and cytokine-driven cell and gene therapies that weaponize the body\u2019s immune system to treat the millions of people globally diagnosed with a solid tumor each year. With its multiplatform approach, Ziopharm is at the forefront of immuno-oncology with a goal to treat any type of &hellip; Continue reading &quot;Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T14:18:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020\",\"datePublished\":\"2020-11-13T14:18:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/\"},\"wordCount\":245,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/\",\"name\":\"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=\",\"datePublished\":\"2020-11-13T14:18:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/","og_locale":"en_US","og_type":"article","og_title":"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020 - Market Newsdesk","og_description":"BOSTON, Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a fireside chat at the Jefferies Virtual London Healthcare Conference on November 19, 2020 at 1:45 pm ET. To access the live webcast presentation, or the subsequent archived recording, please visit the \u201cInvestors\u201d section of the Ziopharm website at www.ziopharm.com. About\u00a0Ziopharm Oncology, Inc.Ziopharm is developing non-viral and cytokine-driven cell and gene therapies that weaponize the body\u2019s immune system to treat the millions of people globally diagnosed with a solid tumor each year. With its multiplatform approach, Ziopharm is at the forefront of immuno-oncology with a goal to treat any type of &hellip; Continue reading \"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T14:18:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020","datePublished":"2020-11-13T14:18:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/"},"wordCount":245,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/","name":"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=","datePublished":"2020-11-13T14:18:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTYwNiMzODI1OTk0IzIwMDc1NTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ziopharm-oncology-to-participate-in-jefferies-virtual-london-healthcare-conference-on-november-19-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380895"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380895\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}